#InBody #BodyComposition #HealthInnovation #ObesityResearch #PreventiveMedicine To view or add a comment, sign in As we head into #ObesityWeek 2025 in Atlanta, the meeting is shaping up to be a reality check for how science, access, and patient experience must now converge
Some more recent trials permitted prior GLP-1 exposure beyond a 6- to 12-month washout period, partially capturing retreatment effects, whereas such exposure was likely minimal in earlier semaglutide trials such as STEP 6
Semaglutide is a GLP 1 receptor agonist, meaning it mimics a natural hormone involved in appetite regulation, digestion, and blood sugar control
Obesity: identification, assessment and management (NG246)
Expression of the MTNR1B gene is seen in the retina and the skin